BSX
64
3
IFF
45
-2
WFC
55
6
CF
56
6
PCAR
39
5
ALLE
14
4
EXPD
26
3
SHW
33
2
JNPR
67
2
KR
46
-3
BK
55
-2
EQT
33
-4
VNO
60
4
ETR
68
5
XYL
25
2
MSFT
46
3
FLR
46
4
PNC
56
6
MAT
47
4
PSA
43
3
BSX
64
3
IFF
45
-2
WFC
55
6
CF
56
6
PCAR
39
5
ALLE
14
4
EXPD
26
3
SHW
33
2
JNPR
67
2
KR
46
-3
BK
55
-2
EQT
33
-4
VNO
60
4
ETR
68
5
XYL
25
2
MSFT
46
3
FLR
46
4
PNC
56
6
MAT
47
4
PSA
43
3
Financhill
Back

Knorr-Bremse AG 10K Form

Sell
33

KNBHF
Knorr-Bremse AG

Last Price:
$70.07
Seasonality Move:
2.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KNBHF News And Ratings

See the #1 stock for the next 7 days that we like better than KNBHF

KNBHF Financial Statistics

Sales & Book Value

Annual Sales: $8.6B
Cash Flow: $196.8M
Price / Cash Flow: 14.54
Annual Sales: $20.53
Price / Book: 3.41

Profitability

EPS (TTM): 4.10870
Net Income (TTM): $650.5M
Gross Margin: $4.3B
Return on Equity: 20.26%
Return on Assets: 7.06%

Knorr-Bremse AG Earnings Forecast

Key Knorr-Bremse AG Financial Ratios

  • The Gross Profit Margin over the past 9 years for KNBHF is 50.67%.
  • The Selling, General & Administrative Expenses for KNBHF have been equal to 1.59% of Gross Profit Margin.
  • The Research & Development expenses have been 0.79% of Revenue.
  • The Interest Expense is 16.86% of Operating Income.
  • The Net Earning history of KNBHF is 6.97% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Knorr-Bremse AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Machinery
Sector: Industrials
Current Symbol: KNBHF
Website: knorr-bremse.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.64
Quick Ratio: 1.16

Price-to-Earnings

Trailing P/E Ratio: 18.87
Forward P/E Ratio: 0

KNBHF Technical Analysis vs Fundamental Analysis

Sell
33
Knorr-Bremse AG (KNBHF) is a Sell

Is Knorr-Bremse AG a Buy or a Sell?

  • Knorr-Bremse AG stock is rated a Sell
    The current Knorr-Bremse AG [KNBHF] share price is $70.07. The Score for KNBHF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.